University of Pennsylvania - Abramson Comprehensive Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
University of Pennsylvania - Abramson Comprehensive Cancer Center has participated in 1 clinical trials.
Therapeutic areas: Metastatic Differentiated Thyroid Cancer, Metastatic Poorly Differentiated Thyroid Cancer, Metastatic Anaplastic Thyroid Cancer.
Sponsors: University of Pennsylvania.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pennsylvania - Abramson Comprehensive Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pennsylvania - Abramson Comprehensive Cancer Center has 1 clinical trials on record. Their work covers Metastatic Differentiated Thyroid Cancer, Metastatic Poorly Differentiated Thyroid Cancer, Metastatic Anaplastic Thyroid Cancer.
University of Pennsylvania - Abramson Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.